Study: Melanoma cells get hooked on vemurafenib

01/15/2013 | Dermatology Times

Melanoma cells treated with vemurafenib eventually use the drug to fuel growth of rapidly progressing drug-resistant tumors, a study in mice found. Dosing intermittently may prevent the growth of drug-resistant tumors, researchers said.

View Full Article in:

Dermatology Times